Muscle News and Research

RSS

BioVentrix announces First-in-Man milestone for PliCath heart failure system

BioVentrix, developer of the PliCath HF™ System for use in Epicardial Catheter-based Ventricular Reconstruction (ECVR), today announced achievement of its First-in-Man milestone, performed on a 52-year-old male heart failure patient in Krakow, Poland. The PliCath HF System is designed to treat heart failure (HF) by reducing the enlarged Left Ventricle (LV) through an anchoring system that is delivered across the cardiac chambers with the use of a catheter.

9 Aug 2010

GTx second-quarter net loss increases to $12.9 million

GTx, Inc. today reported financial results for the second quarter of 2010. The net loss for the quarter ended June 30, 2010 was $12.9 million compared with a net loss of $11.3 million for the quarter ended June 30, 2009. The net loss for the second quarter of 2010 included a $1.7 million non-cash impairment charge related to the conclusion of the Phase III clinical trial of toremifene 20 mg.

9 Aug 2010

Researchers examine differences in eating habits of African Americans

7 Aug 2010

UCSF researchers discover new technology purifying special types of stem cells

UCSF researchers are reporting the first success in very rapidly purifying one type of embryonic stem cell from a mix of many different types of embryonic stem cells in the culture dish. The technique, which avoids the need to genetically alter the cells to distinguish them, is a key advance, the researchers say, for obtaining the appropriate cells for repairing specific damaged tissues.

7 Aug 2010

S-ICD subcutaneous implantable defibrillator restores normal heartbeat in high risk cardiac arrest

Scottsdale Healthcare is the only Arizona hospital system testing a new under-the-skin device that uses an electrical shock to interrupt possibly fatal heart rhythms, restoring a normal heartbeat for patients at high risk of sudden cardiac arrest.The first Arizona patient received the device Thursday at Scottsdale Healthcare Shea Medical Center. Scottsdale Healthcare is the only Phoenix area hospital and one of only 35 in the world participating in the study.

7 Aug 2010

Salamander research findings bring scientists closer to future regenerative therapies

Tissue regeneration in salamanders and newts seems like it should be the stuff of science fiction. But it happens routinely. Why can't we mammals just re-grow a limb or churn out a few new heart muscle cells as needed? New research suggests there might be a very good reason: Restricting our cells' ability to pop in and out of the cell cycle at will - a prerequisite for the cell division necessary to make new tissue - reduces the chances that they'll run amok and form potentially deadly cancers.

6 Aug 2010

Survey reveals need for nutrition education among African Americans for disease prevention, management

Researchers looking for differences in eating habits of African Americans based on whether or not they had Type 2 diabetes uncovered an unexpected result: No matter what the blood sugar level was, the dietary intakes were pretty much the same.African Americans are 1.8 times more likely to develop Type 2 diabetes and 1.4 times more likely to be obese than are non-Hispanic whites, according to federal health agencies. Obesity is a leading risk factor for development of diabetes, a condition that results when the body cannot properly use insulin to transfer sugar from the blood to muscle and fat cells that use glucose for energy.

6 Aug 2010

Scientists find new way to make beating heart cells from body's own cells

Scientists at the Gladstone Institute of Cardiovascular Disease have found a new way to make beating heart cells from the body's own cells that could help regenerate damaged hearts. Over 5 million Americans suffer from heart failure because the heart has virtually no ability to repair itself after a heart attack.

6 Aug 2010

Scientists find molecular cocktail to transform non-muscle cells into cardiac muscle

In heart disease, cardiac muscle gradually dies off and, with little or no way to regenerate those cells, that can ultimately lead the heart to fail. But scientists reporting in the August 6th issue of Cell, a Cell Press publication, might have found a way to fix those losses. They've devised a three-ingredient molecular cocktail that transforms fibroblasts - structural cells that the heart is chock full of - directly into beating heart cells.

6 Aug 2010

Repligen total revenue for first-quarter fiscal 2011 increases 39% to $7.01 million

Repligen Corporation today reported results for the first quarter of fiscal year 2011, ended June 30, 2010. Total revenue for the first quarter was $7,010,000 compared to total revenue of $5,061,000 for the first quarter of fiscal year 2010, an increase of $1,949,000 or 39%. Bioprocessing product revenue for the first quarter was $4,269,000 compared to $2,473,000 for the first quarter of fiscal 2010, an increase of $1,796,000 or 73%.

5 Aug 2010

Genomic sequence of living marine sponge reveals some basic information about cancer: Scientists

This week's publication of the complete genomic sequence of a living marine sponge reveals genes dating back hundreds of millions of years -- a result far exceeding the expectations of the scientific world.

5 Aug 2010

Abiomed first-quarter fiscal 2011 revenue increases 11% to $22.0 million

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2011 revenue of $22.0 million, up 11% compared to the same period of fiscal 2010.

5 Aug 2010

Certain proteins, genes play key role in regenerating lost body parts: Research

Another option may be on the horizon for patients who lose limbs due to war, accident, or disease. Instead of using artificial legs or arms, patients actually may regrow their own missing limbs. An article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine, focuses on research efforts to turn the long-standing dream of human limb regeneration into reality.

5 Aug 2010

Long-term exposure to valproate leads to bone loss: Study

Scientists are reporting a possible explanation for the bone loss that may occur following long-term use of a medicine widely used to treat epilepsy, bipolar disorder, and other conditions. The drug, valproate, appears to reduce the formation of two key proteins important for bone strength, they said. Their study, which offers a solution to a long-standing mystery, appears in ACS' monthly Journal of Proteome Research.

5 Aug 2010

Tips for healthy eating at college

For college students, the campus dining hall offers a tantalizing feast: ice-cream sundaes every night, thirty varieties of cereal and a limitless supply of french fries."It's like a smorgasborg on a cruise ship," said Cynthia Bulik, PhD, director of the Eating Disorders Program at the UNC School of Medicine. All-you-can-eat dining halls, along with changes in exercise habits, have been blamed for the "freshman 15," in which first-year students gain weight.

5 Aug 2010

Acceleron's ACE-031 protein therapeutic for DMD receives FDA Fast Track designation

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it received FDA Fast Track designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients suffer from the progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.

5 Aug 2010

Fractures are major concern for U.S. high school athletes: Study

The popularity of high school sports in the United States has continued to increase over the past decade, with more than 7.5 million athletes participating in school sports during the 2008-09 academic year. A new study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital found that 95 percent of fractures required costly diagnostic imaging, including X-rays, MRIs and CT scans, and 16 percent required surgical repair.

4 Aug 2010

New article published in Journal of Surgical Research highlights PACE technology

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today announced that an article titled "Microvascular Response to Shock Wave Application in Striated Skin Muscle" was recently published in the on-line edition of the Journal of Surgical Research.

4 Aug 2010

Exercise, restricted-calorie diets help to stave off mental, physical degeneration of aging: Research

Harvard University researchers have uncovered a mechanism through which caloric restriction and exercise delay some of the debilitating effects of aging by rejuvenating connections between nerves and the muscles that they control.

3 Aug 2010

miRagen Therapeutics develop MicroRNA based therapeutics for cardiovascular and muscle disease

miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today the publication of data demonstrating the essential role of microRNA-451 (miR-451) in the regulation of erythropoiesis, the process of red blood cell production in the body.

3 Aug 2010

Muscle News and Research

BioVentrix announces First-in-Man milestone for PliCath heart failure system

GTx second-quarter net loss increases to $12.9 million

Researchers examine differences in eating habits of African Americans

UCSF researchers discover new technology purifying special types of stem cells

S-ICD subcutaneous implantable defibrillator restores normal heartbeat in high risk cardiac arrest

Salamander research findings bring scientists closer to future regenerative therapies

Survey reveals need for nutrition education among African Americans for disease prevention, management

Scientists find new way to make beating heart cells from body's own cells

Scientists find molecular cocktail to transform non-muscle cells into cardiac muscle

Repligen total revenue for first-quarter fiscal 2011 increases 39% to $7.01 million

Genomic sequence of living marine sponge reveals some basic information about cancer: Scientists

Abiomed first-quarter fiscal 2011 revenue increases 11% to $22.0 million

Certain proteins, genes play key role in regenerating lost body parts: Research

Long-term exposure to valproate leads to bone loss: Study

Tips for healthy eating at college

Acceleron's ACE-031 protein therapeutic for DMD receives FDA Fast Track designation

Fractures are major concern for U.S. high school athletes: Study

New article published in Journal of Surgical Research highlights PACE technology

Exercise, restricted-calorie diets help to stave off mental, physical degeneration of aging: Research

miRagen Therapeutics develop MicroRNA based therapeutics for cardiovascular and muscle disease

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News